Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Carboplatin CBDCA

Fujii M, Nameki H, Kawaura M, et al. A dose finding study of carboplatin (CBDCA) + UFT in head and neck cancer. ProcAm Soc Clin Oncol 1998 18 406a (abstr 1564). [Pg.43]

Choy H, DeVore RF, Porter LL, et al. Phase I trial of outpatient weekly docetaxel (DTX) Carboplatin (CBDCA) and concurrent thoracic radiation therapy (TRT) for stage III unresectable non-small-cell lung cancer A Vanderbilt Cancer Center Affiliate Network (VCCAN) Trial. Pro Am Soc Clin Oncol 1999 18 475a (abstract 1833). [Pg.87]

Murakami H, Kubota K, Ohe Y, et al. Phase I study of weekly docetaxel (DTX) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) for stage III non-small cell lung cancer (NSCLC). Lung Cancer 2000 29(Suppl 1) 111 (abstract 367). [Pg.87]

Jacobs MC, Eisenberger M, Oh MC, et al. Carboplatin (CBDCA) and radiotherapy for stage IV carcinoma of the head and neck a phase I-II study. Int J Radiat Oncol Biol Phys 1989 17 361-363. [Pg.171]

Lind MJ, McGregor J, Timms MS, Brown D, Palmer P. Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. Eur J Cancer Clin Oncol 1988 24(9) 1471-9. [Pg.2871]

Figure 10.3.1. Second generation of cisplatin analogues (a) carboplatin (CBDCA, JM 8) (b) spiroplatin (TNO 6) (c) oxoplatin (d) iproplatin (CHIP, JM 9). Figure 10.3.1. Second generation of cisplatin analogues (a) carboplatin (CBDCA, JM 8) (b) spiroplatin (TNO 6) (c) oxoplatin (d) iproplatin (CHIP, JM 9).
Pt Carboplatin [Pt(NH3)2(CBDCA)] CBDCA= cyclobutanedicarboxylic acid Anticancer agent... [Pg.269]

Ring-opened adducts of carboplatin can form not only from reactions with nucleotides, but also by the attack of sulfur amino acids [44]. Reactions with thioether ligands are much more rapid compared with thiols. Surprisingly very stable ring-opened species such as [Pt(CBDCA-0)(NH3)2(L-HMet-S)] are formed, which has a half-life for Met-S,N closure of 28 h at 310 K. Such an intermediate could also play a role in the biological activity of this drug. [Pg.314]

Cdrboplatin, Carboplatin, Poraplatin, CBDCA, JM8, NSC-241240, ris-diammine( I. I -cyclobulanedicarboxala-... [Pg.431]

See other pages where Carboplatin CBDCA is mentioned: [Pg.14]    [Pg.85]    [Pg.868]    [Pg.109]    [Pg.14]    [Pg.85]    [Pg.868]    [Pg.109]    [Pg.184]    [Pg.280]    [Pg.280]    [Pg.281]    [Pg.290]    [Pg.184]    [Pg.305]    [Pg.45]    [Pg.46]    [Pg.314]    [Pg.315]    [Pg.8]    [Pg.66]    [Pg.68]    [Pg.140]    [Pg.114]    [Pg.124]    [Pg.169]    [Pg.270]   
See also in sourсe #XX -- [ Pg.8 ]



SEARCH



CBDCA

Carboplatin

Carboplatin (CBDCA toxicity

© 2024 chempedia.info